文献速递心律失常心力衰竭与心肌病瓣膜病与结构性心脏病

整合素β1D缺失介导RyR2功能障碍导致致心律失常性右室心肌病儿茶酚胺敏感性室速

Integrin β1D Deficiency-Mediated RyR2 Dysfunction Contributes to Catecholamine-Sensitive Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy.
PubMed 文献 · Circulation · 2020-03-03

该研究通过蛋白质谱发现ARVC心脏中整合素β1下调而钙处理蛋白不变,构建心脏特异性β1D敲除小鼠并开展功能成像与生化分析,发现β1D缺失导致RyR2 Ser-2030过度磷酸化及钙处理异常,引发儿茶酚胺敏感性多形性室速,机制涉及DSP缺失经ERK1/2-纤连蛋白-泛素/溶酶体通路诱导β1D缺乏。

要点

  • ARVC患者左室组织中整合素β1D缺失与RyR2 Ser-2030过度磷酸化并存。
  • β1D敲除小鼠心脏功能形态正常,但出现儿茶酚胺敏感性多形性室速。
  • DSP缺失经ERK1/2-纤连蛋白-泛素/溶酶体通路导致β1D缺乏。

核心结论

  • 整合素β1D缺失是ARVC患者室性心律失常风险增加的新机制。

研究设计与样本

  • 研究采用蛋白质谱分析、心脏特异性β1D敲除小鼠模型、功能成像和生化分析。
  • 纳入ARVC患者左室组织,并与缺血性或肥厚型心肌病患者组织对比。

主要发现

  • ARVC患者左室组织中整合素β1D下调且RyR2 Ser-2030过度磷酸化,而缺血性或肥厚型心肌病患者无此改变。
  • 纯化的整合素β1D蛋白可降低RyR2开放概率和平均开放时间,增加平均关闭时间,从而稳定RyR2功能。
  • β1D敲除小鼠心脏功能和形态正常,但表现出儿茶酚胺敏感性多形性室速,伴RyR2 Ser-2030磷酸化增加和钙处理异常。
  • DSP缺失通过ERK1/2-纤连蛋白-泛素/溶酶体通路诱导ARVC中整合素β1D缺乏。

临床怎么用

  • 整合素β1D缺失和RyR2 Ser-2030过度磷酸化可作为ARVC室性心律失常风险的潜在生物标志物。
  • 针对整合素β1D-RyR2轴可能为ARVC儿茶酚胺敏感性室速提供新的治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a hereditary heart disease characterized by fatty infiltration, life-threatening arrhythmias, and increased risk of sudden cardiac death. The guideline for management of ARVC in patients is to improve quality of life by reducing arrhythmic symptoms and to prevent sudden cardiac death. However, the mechanism underlying ARVC-associated cardiac arrhythmias remains poorly understood. METHODS: Using protein mass spectrometry analyses, we identified that integrin β1 is downregulated in ARVC hearts without changes to Ca2+-handling proteins. As adult cardiomyocytes express only the β1D isoform, we generated a cardiac specific β1D knockout mouse model and performed functional imaging and biochemical analyses to determine the consequences of integrin β1D loss on function in the heart in vivo and in vitro. RESULTS: Integrin β1D deficiency and RyR2 Ser-2030 hyperphosphorylation were detected by Western blotting in left ventricular tissues from patients with ARVC but not in patients with ischemic or hypertrophic cardiomyopathy. Using lipid bilayer patch clamp single channel recordings, we found that purified integrin β1D protein could stabilize RyR2 function by decreasing RyR2 open probability, mean open time, and increasing mean close time. Also, β1D knockout mice exhibited normal cardiac function and morphology but presented with catecholamine-sensitive polymorphic ventricular tachycardia, consistent with increased RyR2 Ser-2030 phosphorylation and aberrant Ca2+ handling in β1D knockout cardiomyocytes. Mechanistically, we revealed that loss of DSP (desmoplakin) induces integrin β1D deficiency in ARVC mediated through an ERK1/2 (extracellular signal-regulated kinase 1 and 2)-fibronectin-ubiquitin/lysosome pathway. CONCLUSIONS: Our data suggest that integrin β1D deficiency represents a novel mechanism underlying the increased risk of ventricular arrhythmias in patients with ARVC.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Wang Y, Li C, Shi L, et al. Integrin β1D Deficiency-Mediated RyR2 Dysfunction Contributes to Catecholamine-Sensitive Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy. Circulation. 2020. PMID: 32122157. doi:10.1161/CIRCULATIONAHA.119.043504

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。